best glp-1 drugs Compound versions of for weight loss halted by FDA GLP-1 drugs are dominating the

The GLP-1 receptor agonist semaglutide reduces risks of kidney function loss, kidney failure, cardiovascular events, cardiovascular death and all-cause mortality in people with chronic kidney disease and type 2 diabetes

For diabetics, I am going to make a bold prediction that this drug becomes the standard of care for most Type 2 diabetics

Healthcare advise should always be sought, especially if already taking prescription medication

This eliminates the absorption concern entirely

others don't, with only 19% of large employers covering GLP-1 drugs for weight loss

In early 2025, Pfizer scrapped its own experimental obesity pill (an oral GLP-1 candidate) due to safety concerns ( [35] ) ( [8] )